Coagulation monitoring in postcardiotomy ECMO: conventional tests, point-of-care, or both?

Minerva Anestesiol. 2016 Aug;82(8):858-66. Epub 2016 Apr 6.

Abstract

Background: The aim of this study was to assess the association of the coagulation point-of-care (POC) tests activated clotting time (ACT) and thromboelastography-derived parameters reaction time (R-time) and maximum amplitude (MA) with the standard coagulation tests during postcardiotomy extracorporeal membrane oxygenation (ECMO), finding adequate values predictive for the target range of the standard coagulation tests.

Methods: Thirty-one patients undergoing postcardiotomy ECMO with heparin anticoagulation were analyzed. Paired data of the POC tests and standard coagulation tests were analyzed for association and positive predictive value (PPV).

Results: The following target range values for standard coagulation test were settled: activated partial thromboplastin time (aPTT) 50-70 seconds; international normalized ratio (INR) 1.5-2.5; platelet count >50,000 cells/µL; fibrinogen >150 mg/dL. The best predictor for the desired aPTT range was an ACT of 162-185 seconds. A combination of an ACT<162 seconds with an R-time <10 minutes had an 83% PPV for a short aPTT. A combination of an ACT>185 seconds with an R-time >27 minutes had a 71% PPV for a long aPTT. No predictive ability of the POC tests was found in terms of the optimal INR range. An MA value <41 mm had a 75% PPV for a low platelet count or fibrinogen level.

Conclusions: Diagnostic-therapeutic algorithms based on coagulation POC-tests may be useful to manage anticoagulation during postcardiotomy ECMO. The best PPV for prompting therapeutic decision is provided by a combination of ACT and visco-elastic tests.

MeSH terms

  • Anticoagulants
  • Blood Coagulation Tests
  • Blood Coagulation*
  • Cardiac Surgical Procedures*
  • Extracorporeal Membrane Oxygenation*
  • Heparin
  • Humans
  • International Normalized Ratio
  • Myocardium
  • Partial Thromboplastin Time
  • Platelet Count
  • Point-of-Care Systems*
  • Postoperative Care
  • Thrombelastography

Substances

  • Anticoagulants
  • Heparin